Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
IMPEL PHARMACEUTICALS INC (IMPL)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
15 Dec 2023
Vivo Capital VIII, LLC
10% Owner
IMPEL PHARMACEUTICALS INC
(IMPL)
2,029,495
-22%
575,000
$0.13
$74,131.33
BUY
19 Nov 2021
NELSON TIMOTHY S
Director
IMPEL NEUROPHARMA INC
(IMPL)
10,000
+100%
10,000
$10.76
$107,554.00
BUY
18 Aug 2021
ADAMS ADRIAN
COB, CEO and President, Director, Officer
IMPEL NEUROPHARMA INC
(IMPL)
17,203
+715%
20,000
$13.99
$279,789.60
BUY
27 Apr 2021
KKR Iris Investors LLC
10% Owner
IMPEL NEUROPHARMA INC
(IMPL)
3,802,638
+40%
1,100,000
$15.00
$16,500,000.00
BUY
27 Apr 2021
5AM Ventures V, L.P.
10% Owner
IMPEL NEUROPHARMA INC
(IMPL)
575,000
+100%
575,000
$15.00
$8,625,000.00
BUY
27 Apr 2021
Norwest Venture Partners XIV, LP
10% Owner
IMPEL NEUROPHARMA INC
(IMPL)
3,077,198
+36%
825,000
$15.00
$12,375,000.00
BUY
27 Apr 2021
Vivo Capital VIII, LLC
10% Owner
IMPEL NEUROPHARMA INC
(IMPL)
2,535,115
+29%
575,000
$15.00
$8,625,000.00
BUY
27 Apr 2021
venBio Global Strategic Fund II L.P.
10% Owner
IMPEL NEUROPHARMA INC
(IMPL)
2,759,791
+19%
450,000
$15.00
$6,750,000.00
Home